BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 203 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $401,000 | -92.8% | 11,800 | -88.4% | 0.21% | -67.2% |
| Q4 2019 | $5,547,000 | +18.3% | 101,900 | -9.3% | 0.65% | +8.3% |
| Q3 2019 | $4,689,000 | -36.1% | 112,400 | -32.9% | 0.60% | +17.9% |
| Q2 2019 | $7,339,000 | -8.1% | 167,600 | +8.1% | 0.51% | +37.9% |
| Q1 2019 | $7,982,000 | +474.2% | 155,100 | +312.5% | 0.37% | +284.4% |
| Q4 2018 | $1,390,000 | – | 37,600 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |